Progress toward precision medicine in frontline treatment of metastatic renal cell carcinoma Editorial
| Author: | Singla, N. |
| Title: | Progress toward precision medicine in frontline treatment of metastatic renal cell carcinoma |
| Keywords: | bevacizumab; sunitinib; advanced cancer; cancer combination chemotherapy; drug efficacy; drug safety; note; gene; ipilimumab; cancer immunotherapy; gene expression; cancer therapy; renal cell carcinoma; kidney carcinoma; drug response; molecular biology; vhl gene; axitinib; cytotoxic t lymphocyte antigen 4; kidney metastasis; everolimus; personalized medicine; programmed death 1 ligand 1; molecularly targeted therapy; nivolumab; human; pembrolizumab; atezolizumab |
| Journal Title: | JAMA Oncology |
| Volume: | 6 |
| Issue: | 1 |
| ISSN: | 2374-2437 |
| Publisher: | American Medical Association |
| Date Published: | 2020-01-01 |
| Start Page: | 25 |
| End Page: | 26 |
| Language: | English |
| DOI: | 10.1001/jamaoncol.2019.4716 |
| PUBMED: | 31804664 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Note -- Export Date: 3 February 2020 -- Source: Scopus |
